Call for Comments on New ADA Clinical Practice Guideline for the Evaluation of Potentially Malignant Disorders in the Oral Cavity
An expert panel convened by the American Dental Association’s Council on Scientific Affairs is working with the ADA Center for Evidence-Based Dentistry (EBD) to develop a clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity. In April, the public was given a chance to comment on the guideline’s recommendation statements, which are available below.
View recommendation statements (PDF)
The ADA’s clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity was developed through a review of the best available scientific evidence. This review resulted in the recommendation statements presented above. These recommendations will appear in the clinical practice guideline when it is published in the October issue of the Journal of the American Dental Association.
The chair of the expert panel developing the guideline, Dr. Mark Lingen, will also be presenting these recommendations during a talk titled “ADA Clinical Practice Guidelines on the Evaluation of Oral Cancer” on the ADA Science Institute Stage at the ADA 2017 national meeting.
The deadline for comments was May 1, 2017. All submitted feedback is being reviewed by the Center for EBD and will aid in the development of the ADA’s upcoming guideline.
Thank you for all your comments.
The comment period is now closed. The American Dental Association’s Center for Evidence-Based Dentistry, working with an expert panel convened by the ADA’s Council on Scientific Affairs, is currently evaluating all comments received.